Nipro offers the only dialyzers in the U.S. market that are made without BPA and DEHP in any of the product components. This ensures patients receive treatment with a dialyzer that is safe and gentle while limiting the exposure to these well-known endocrine disruptors.
In addition, the Nipro Cellentia dialyzer is designed with a CTA membrane, which offers a solution for treating patients who have dif culty tolerating standard hemodialysis alters made with polysulfone, polyethersulfone, or polyarylethersulfone.
Dialyzer membranes are important in the success of hemodialysis therapies and adequacy. Matching dialyzer performance to the patient needs is critical in meeting the prescribed clearance goals.
As part of Nipro’s commitment to quality, all of its dialyzers are designed to meet high performance membrane (HPM) standards. The HPM classi cation system is used to identify hollow- ber dialyzers that deliver an advanced level of performance.
A cross-reference of dialyzers that contain BPA or contain no BPA